Sanara MedTech Inc. Common Stock SMTI
Analyst Ratings
- Consensus
- Moderate Buy — 2 Buy · 1 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $34.00 (-3.2% downside)
Key Stats
- Today's Range
- $34.71 – $35.16
- 50-Day Range
- $23.00 – $35.24
- 52-Week Range
- $16.05 – $35.95
- Volume
- 196K shs
- Average Volume
- 315K shs
- Market Cap
- $322.59 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
About Sanara MedTech Inc. Common Stock
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Related Stocks
Compare head-to-head: SMTI vs STE·SMTI vs ZBH·SMTI vs MSA·SMTI vs INGN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.